Hanger Inc. (HNGR)
(Delayed Data from NYSE)
$20.53 USD
+0.21 (1.03%)
Updated May 3, 2019 04:06 PM ET
After-Market: $20.51 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$20.53 USD
+0.21 (1.03%)
Updated May 3, 2019 04:06 PM ET
After-Market: $20.51 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
3 Stocks to Watch From the Pandemic-Hit Outpatient Home Health Industry
by Debanjana Dey
Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. AMED, ADUS and HNGR are well poised to gain from the prospects.
Is Aerie Pharmaceuticals (AERI) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how Aerie Pharmaceuticals (AERI) and Hanger (HNGR) have performed compared to their sector so far this year.
Fast-paced Momentum Stock Hanger (HNGR) Is Still Trading at a Bargain
by Zacks Equity Research
Hanger (HNGR) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Is Hanger (HNGR) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Has Brookdale Senior Living (BKD) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Brookdale Senior Living (BKD) and Hanger (HNGR) have performed compared to their sector so far this year.
Molina Healthcare (MOH) to Get New Medicaid Contract in Iowa
by Zacks Equity Research
Molina Healthcare's (MOH) Iowa health plan is likely to commence on Jul 1 next year.
Is Hanger (HNGR) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Alignment Healthcare (ALHC) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Alignment Healthcare (ALHC) and Hanger (HNGR) have performed compared to their sector so far this year.
Encompass (EHC) Opens Its 4th Inpatient Rehab Unit in Illinois
by Zacks Equity Research
Encompass Health's (EHC) Quad Cities Rehabilitation Institute has 40 beds and serves patients who are recovering from enervating and complex illnesses and injuries.
What's in the Cards for Medtronic (MDT) in Q1 Earnings?
by Zacks Equity Research
Going by the industry-wide macro trend, we expect Medtronic (MDT) to once again report an adverse effect related to the global supply chain issues in fiscal Q1.
Fast-paced Momentum Stock Hanger (HNGR) Is Still Trading at a Bargain
by Zacks Equity Research
Hanger (HNGR) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Hanger (HNGR) Stock Jumps 25%: Will It Continue to Soar?
by Zacks Equity Research
Hanger (HNGR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Chemed (CHE) Surges 3.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Chemed (CHE) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Quest Diagnostics (DGX) Beats Q1 Earnings Estimates
by Zacks Equity Research
Quest Diagnostics (DGX) delivered earnings and revenue surprises of 10.65% and 1.02%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Hanger (HNGR) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Hanger (HNGR) delivered earnings and revenue surprises of 5.26% and 0.16%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for February 11th
by Zacks Equity Research
ALGN, CNHI, EPC, GHM, and HNGR have been added to the Zacks Rank #5 (Strong Sell) List on February 11, 2022.
Hanger (HNGR) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Hanger (HNGR) delivered earnings and revenue surprises of 56.00% and 2.69%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Hanger (HNGR) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Hanger (HNGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is Hanger (HNGR) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
New Strong Buy Stocks for October 6th
by Zacks Equity Research
DKS, MUSA, BDC, HNGR, and VEC have been added to the Zacks Rank #1 (Strong Buy) List on October 6, 2021.
New Strong Buy Stocks for September 27th
by Zacks Equity Research
SMP, AMOT, HNGR, PPC, and TRNS have been added to the Zacks Rank #1 (Strong Buy) List on September 27, 2021.
New Strong Buy Stocks for September 13th
by Zacks Equity Research
DSKE, HNGR, SCSC, TTMI, and CC have been added to the Zacks Rank #1 (Strong Buy) List on September 13, 2021.
New Strong Buy Stocks for August 30th
by Zacks Equity Research
DSKE, HNGR, GPS, SCSC, and RDNT have been added to the Zacks Rank #1 (Strong Buy) List on August 30, 2021
Hanger (HNGR) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Hanger (HNGR) delivered earnings and revenue surprises of 28.57% and 3.14%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Hanger (HNGR) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Hanger (HNGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.